Overview
BIVI market data
Price History
No market bars yet for BIVI. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for BIVI. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 20, 2026, 8:56 AM
BioVie Files Prospectus To Offer Up To $300M In SecuritiesBenzinga · Jun 18, 2026, 9:30 PM
BioVie Announces Full Enrollment Of ADDRESS-LC Phase 2 Trial Evaluating Drug Candidate Bezisterim For Treatment Of Neurological Symptoms Of Long COVIDBenzinga · May 26, 2026, 12:06 PM
BioVie Announces Completion Of Last Patient Evaluation Visit In The SUNRISE-PD Phase 2 Trial Evaluating Its Drug Candidate Bezisterim In Early Stage Parkinson's DiseaseBenzinga · May 18, 2026, 12:05 PM